Skip to main content
. 2021 Feb 3;16(3):158–164. doi: 10.1016/j.joto.2021.01.005

Table 1.

Descriptive analysis of COVID-19 patients (test group).

Continuous variables Mean
(± Standard deviation)
Categorical variables Frequency (%)
Age (years) a 63±6.80 Gender(male) 78.6
PO2/FiO2 admission a 276.44±54.98 Obstructive sleep apnea 14.3
Sedimentation rate (mm; 1st hour)a 70.67±26.45 Autoimune disease 10.7
Fibrinogen (mg/dl; clauss)a 597.56±134.24 Diabetes Mellitus 28.6
D-Dimers (ng/mL)a 352.78±105.12 Hypertension 42.9
Activated Partial thromboplastin time (seconds) a 33.93±3.23 Dyslipidemia 39.3
Prothrombin time (seconds) a 13.46±1.10 Chronic Pulmonary disease 7.1
Ferritin (ng/mL) a 1715±466,79 Asthma 3.6
Reactive C protein (mg/L) a 90.82±40.90 Smoking 17.9
Procalcitonin (ng/mL)a 0.25±0.21 Rhinosinusitis 10.7
HbA1C (%) 6.922±1.49 Obesity 39.3
Symptoms-to-audiogram (days) 11±4.24 Previous chemotherapy 7.1
PO2/FIO2 audiogramb 229.67±85.79 Dexamethasone treatment d 92.7
Length-of-stay (days) c 11.56±3.17 Remdesivir treatmentd 75
a

- Measured at hospital admission.

b

- same day or most recent value from the audiogram day.

c

- from admission to hospital discharge.

d

- at the time of audiogram performance; Note: All values shown are valid percent and exclude missing values from the equation.